Acasti Pharma Inc (ACST)
Company Info
| ISIN | CA00430K8730 |
|---|---|
| CUSIP | 00430K105 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $25.94M |
|---|---|
| EPS | -$5.68 |
| Revenue (TTM) | $115.00K |
| Gross Profit (TTM) | $120.00K |
| EBITDA (TTM) | -$12.21M |
| Year Range | $1.72 - $3.84 |
| Target Price | $6.02 |
| Short % | 0.01% |
| Short Ratio | 0.08 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Acasti Pharma Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Acasti Pharma Inc had a return of -3.46% year-to-date (YTD) and -4.20% in the last 12 months. Over the past 10 years, Acasti Pharma Inc had an annualized return of -40.04%, while the S&P 500 had an annualized return of 10.84%, indicating that Acasti Pharma Inc did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -3.46% | 10.00% |
| 1 month | -18.06% | 2.41% |
| 6 months | 27.98% | 16.70% |
| 1 year | -4.20% | 26.85% |
| 5 years (annualized) | -41.77% | 12.81% |
| 10 years (annualized) | -40.04% | 10.84% |
Monthly Returns
The table below presents the monthly returns of ACST, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -14.19% | 34.68% | 2.54% | -18.83% | -3.46% | ||||||||
| 2023 | 41.74% | -27.90% | -10.18% | -1.28% | 18.94% | -2.76% | -18.11% | -20.16% | 35.12% | -15.21% | -8.05% | 33.18% | -3.86% |
| 2022 | -8.73% | -2.61% | 8.93% | -13.93% | -6.68% | -12.45% | -3.47% | -1.75% | -28.28% | -3.00% | -26.01% | 19.63% | -60.24% |
| 2021 | 100.77% | 10.34% | -16.67% | -17.83% | 1.28% | 12.46% | -18.70% | -26.89% | -25.09% | -16.50% | -19.16% | -6.67% | -51.54% |
| 2020 | -70.04% | -41.68% | -11.35% | 60.74% | 3.77% | -25.89% | 62.01% | -67.80% | -18.19% | -7.09% | 55.91% | 12.07% | -86.73% |
| 2019 | 28.62% | 0.93% | -5.56% | -15.00% | 3.78% | 26.69% | 111.40% | -22.41% | 1.07% | -2.65% | 8.15% | 23.12% | 194.51% |
| 2018 | 19.86% | -11.59% | 2.10% | -24.50% | -10.27% | -17.51% | 2.93% | -4.89% | 131.18% | -22.48% | -27.00% | 13.96% | -11.76% |
| 2017 | 1.60% | -1.57% | 8.80% | -5.88% | 0.55% | 2.56% | -0.00% | -2.85% | 10.73% | -9.79% | 30.37% | -43.54% | -24.58% |
| 2016 | -38.82% | -3.85% | 1.33% | -7.24% | 6.38% | -8.00% | 12.32% | -14.19% | 34.39% | -25.03% | 4.48% | -10.71% | -50.98% |
| 2015 | -8.00% | 19.57% | -12.82% | -17.21% | -16.52% | -4.95% | 14.32% | -1.42% | -24.25% | -15.95% | 1.77% | 10.87% | -49.00% |
| 2014 | 1.60% | -0.00% | -9.50% | -12.12% | -14.85% | 18.60% | -2.06% | -5.81% | -18.17% | -29.87% | -23.15% | 20.48% | -60.00% |
| 2013 | 20.82% | -12.31% | -6.58% | 10.80% | 7.63% | 11.42% | 42.40% | -37.97% | -5.20% | -19.41% | -35.08% | 0.81% | -41.91% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ACST is 46, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
ACST (Acasti Pharma Inc)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Acasti Pharma Inc (ACST) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Acasti Pharma Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Acasti Pharma Inc was 99.91%, occurring on Sep 22, 2023. The portfolio has not yet recovered.
The current Acasti Pharma Inc drawdown is 99.86%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.91% | Aug 6, 2013 | 2541 | Sep 22, 2023 | — | — | — |
| -26.08% | Jun 8, 2011 | 28 | Jan 24, 2012 | 1 | Feb 14, 2012 | 29 |
| -22.89% | Dec 7, 2012 | 61 | Mar 21, 2013 | 55 | Jun 11, 2013 | 116 |
| -18.29% | May 18, 2012 | 37 | Nov 8, 2012 | 6 | Nov 30, 2012 | 43 |
| -4.47% | Aug 1, 2013 | 1 | Aug 1, 2013 | 2 | Aug 5, 2013 | 3 |
Volatility
Volatility Chart
The current Acasti Pharma Inc volatility is 15.75%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |